Teva Swallows Another Pill Makerpublished Thu, Mar 18 2010 12:50 GMT
Israeli pharmaceutical company agrees to buy German generics firm Ratiopharm in a deal valued at $5 billion.
Click for more articles from www.forbes.com
|
|